DNA rewires how your cells answer alcohol, nicotine and caffeine
University of Chicago and Johns Hopkins researchers dosed lab-grown cell cultures with alcohol, nicotine and caffeine, then tracked how each cell answered across different genetic backgrounds. Profiling over 1.4 million cells, they found a class of DNA variants tied to disease risk that only surfaces under certain exposures. The aim: predict how your environment hits your genes.
- Original source: medicalxpress.com.
- The source published it on Nov 18, 2026 at 1:40 PM.
- Not verified by major outlets. This story may be false.
- No second outlet has reported it yet. Treat it as a single-source claim.
The team built what it calls "heterogeneous differentiating cultures" — adult cells donated through the International HapMap Project, reprogrammed so they could become any cell type, then grown into 3D clumps that mimic the early stages of development. Those cultures got dosed with alcohol, nicotine or caffeine, and because cells from many donors were pooled together, single-cell sequencing was needed to read each cell's RNA and trace it back to the person it came from. The effort ended up profiling more than 1.4 million cells.
Then came the hunt for eQTLs — DNA variants that line up with how much RNA a nearby gene produces. The baseline version, where expression shifts with genotype but not with treatment, tends to cluster near the start of a gene. The response version, which only appears under an exposure, prefers enhancer regions that crank a gene's activity up. "This is one of the first papers that showed the difference between the two in terms of their genomic features and locations," said Yoav Gilad, Ph.D., professor of medicine and human genetics at the University of Chicago and co-senior author. "The response eQTLs are in different genomic contexts and drive the more dynamic nature of gene regulation, rather than just switching a gene on and off."
That overlap matters. Response eQTLs sit on the same spots as disease-linked variants far more often than baseline ones do. One example from the study: alcohol treatment produced a response eQTL affecting the gene LNX2, specifically in the cells lining the intestine. It lands in an enhancer that overlaps a risk signal for inflammatory bowel disease, a condition that chronically inflames the gastrointestinal tract and damages the intestinal lining. LNX2 is tied to a signaling pathway that helps build and maintain that lining. The researchers are clear this doesn't mean drinking causes IBD — it shows that what a genetic variant does depends on both the exposure and the cell type.
The long game is prediction. "Even in treatments that we characterize in 100 individuals, what you really want to do is predict the response of the 101st," Gilad said, adding that with training data covering both developmental and environmental contexts, AI models could eventually deliver that kind of insight. He pointed to pregnant women, who are tested in very few treatments, leaving clinicians to "balance their intuition and anecdotal evidence" on a risk that is individual to each genotype. Developmental gene-by-environment effects may also stay quiet for decades: Gilad said a developmental quirk could underlie a higher risk of diabetes or heart disease in your 40s or 50s. The study, with Alexis Battle as co-senior author and Wenhe Lin as first author, is published in Cell Genomics.
TopicsUniversity of Chicago · Johns Hopkins University · Yoav Gilad · Alexis Battle · Cell Genomics · LNX2 · inflammatory bowel disease · International HapMap Project
Source: medicalxpress.com
Written by AI from verified reporting.

